Peptydy przeciwdrobnoustrojowe w zwalczaniu patogenów opornych na powszechnie stosowane antybiotyki

• Autorzy: Bagnicka E. , Strzalkowska N. , Jozwik A. , Horbanczuk J. O. , Krzyzewski J. , Zwierzchowski L.

Warianty tytułu

EN

Antimicrobial peptides in overcoming the resistance of pathogens to commonly used antibiotics

• Języki publikacji: PL

Abstrakty

EN

The common abuse of antibiotics during the twentieth century caused the development of many multiresistant pathogens to classic antibiotics. To find new strategies to fight against resistant pathogens is the challenge of the twenty-first century. Since they seem to be natural antibiotics, peptides produced by bacteria, insects, amphibians and mammals with cytotoxic activities against bacteria, mycobacteria, fungi and enveloped viruses are one of the groups with prospects for use in therapy against pathogens. Such peptides protect the cells which produce them. Cationic peptides are a huge group of antimicrobial peptides, consisting of a number of families, e.g. defensins and cathelicidins. Their expression was initially found in phagocyte cells, like macrophages and neutrophiles as well as in epithelial cells. The aim of this study was to present a review of antimicrobial peptides identified in humans and in economically important farm animals and to discuss the possibilities of using them in therapy and prophylaxis.

Słowa kluczowe

PL

czlowiek; zwierzeta gospodarskie; peptydy przeciwdrobnoustrojowe; peptydy anionowe; peptydy kationowe; katelicydyna ludzka; peptydy szpikowe; hepcydyna; granuliny; defensyny

• Wydawca: -
• Czasopismo: Medycyna Weterynaryjna
• Rocznik: 2011
• Tom: 67
• Numer: 08
• Opis fizyczny: s.512-516,bibliogr.

Twórcy

autor

Bagnicka E.

• Instytut Genetyki i Hodowli Zwierząt Polskiej Akademii Nauk w Jastrzębcu, ul.Postępu 1, 05-552 Wólka Kosowska

autor

Strzalkowska N.

autor

Jozwik A.

autor

Horbanczuk J. O.

autor

Krzyzewski J.

autor

Zwierzchowski L.

Bibliografia

• 1. Bagnicka E., Strzałkowska N., Jóźwik A., Krzyżewski J., Horbańczuk J., Zwierzchowski L.: Expression and polymorphism of defensins in farm animals. Acta Biochim. Pol. 2010, 57, 487-497.
• 2. Bao H., She R., Liu T., Zhang Y., Peng K. S., Luo D., Yue Z., Ding Y., Hu Y., Liu W., Zhai L.: Effects of pig antibacterial peptides on growth performance and intestine mucosal immune of broiler chickens. Poult. Sci. 2009, 88, 291-297.
• 3. Boman H. G.: Peptide antibiotics and their role in innate immunity. Annu. Rev. Immunol. 1995, 13, 61-92.
• 4. Brogden K. A., Ackermann M., McCray Jr. P. B., Tack B. F.: Antimicrobial peptides in animals and their role in host defence. Int. J. Antimicrob. Ag. 2003, 22, 465-478.
• 5. Brogden K. A., Klafa V. C., Ackermann M. R., Palmquist D. E., McCray Jr. P. B., Tack B. F.: The ovine cathelicidin SMAP29 kills ovine respiratory pathogens in vitro and in an ovine model of pulmonary infection. Antimicrob. Agents 2001, 45, 331-334.
• 6. Couto M. A., Harwig S. S., Cullor J. S., Hughes J. P., Lehrer R. I.: Identification of eNAP-1, an antimicrobial peptide from equine neutrophils. Infect. Immun. 1992, 60, 3065-3071.
• 7. Couto M. A., Harwig S. S., Lehrer R. I.: Selective inhibition of microbial serine proteases by eNAP-2, an antimicrobial peptide from equine neutrophils. Infect. Immun. 1993, 61, 2991-2994.
• 8. Fales-Williams A. J., Gallup J. M., Rmirez-Romero R., Brogden K. A., Ackermann M. R.: Increased anionic peptide distribution and intensity during progression ansd resolution of bacterial pneumonia. Clin. Diagn. Lab. Immun. 2002, 9, 28-32.
• 9. Falzacappa M. V. V., Muckenthaler M. U.: Hepcidin: Iron-hormone and antimicrobial peptide. Gene 2005, 364, 37-44.
• 10. Gennaro R., Skerlavaj B., Romeo D.: Purification, composition, and activity of two bactenecins, antibacterial peptides of bovine neutrophils. Infec. Immun. 1989, 57, 3142-3146.
• 11. Gordon Y. J., Romanowski E. G.: A review of antimicrobial peptides and their therapeutic potential as anti-infective drugs. Curr. Eye Res. 2005, 30, 505-515.
• 12. Guthmiller J. M., Vargas K. G., Srikantha R., Schomberg L. L., Weistroffer P. L., McCray P. B. JR., Tack B. F.: Susceptibilities of oral bacteria and yeast to mammalian cathelicidins. Antimicrob. Agents 2001, 45, 3216-3219.
• 13. Hancock R. E. W.: Peptide antibiotics. Lancet 1997, 349, 418-422.
• 14. Herasimenka Y., Benincasa M., Mattiuzzo M., Cescutti P., Gennaro R., Rizoo R.: Interaction of anitmicrobial peptides with bacterial polysaccharides from lung pathogens. Peptides 2005, 26, 1127-1132.
• 15. Huang G. T., Zhang H. B., Kim D., Liu L., Ganz T.: A model for antimicrobial gene therapy: demonstration of human beta-defensin 2 antimicrobial activities in vivo. Hum. Gene Ther. 2002, 13, 2017-2025.
• 16. Huttner K. M., Bresinski-Caliguri D. J., Mahoney M. M., Diamond G.: Antimicrobial peptide expression is developmentally regulated in the ovine gastrointenstinal tract. J. Nutr. 1998, 128, 297S-299S.
• 17. Kagan B. L., Selsted M. E., Ganz T., Lehrer R. I.: Antimicrobial defensin peptides form voltage-dependent ion-permeable channels in planar lipid bilayer membranes. PNAS USA 1990, 87, 210-214.
• 18. Kamysz W., Okrój M., Łukasiak J.: Novel properties of antimicrobial peptides. Review. Acta Biochim. Pol. 2003, 50, 461-469.
• 19. Krause A., Neitz S., M H.-J., Schulz A., Forssmann W.-G., Schulz-Knappe P., Adermann K.: LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Letters 2000, 480, 147-150.
• 20. Lehrer R. I., Ganz T.: Antimicrobial peptides in mammalian and insect host defence. Curr. Opin. Immunol. 1999, 11, 23-27.
• 21. Lehrer R. I., Ganz T.: Cathelicidins: a family of endogenous antimicrobial peptides. Curr. Opin. Hematol. 2002, 9, 18-22.
• 22. Leszczyńska K.: Ocena efektów skojarzonego działania antybiotyków z defensynami oraz mieloperoksydazą na szczepy Staphylococcus aureus. Praca dokt., Zakład Mikrobiologii AM, Białystok 1998.
• 23. Lipiński P., Starzyński R. R.: Regulacja ogólnoustrojowej homeostazy żelaza przez hepcydynę. Post. Hig. Med. Dośw. 2004, 58, 65-73.
• 24. Meyerholz D. K., Ackermann M. R.: Antimicrobial peptides and Sufactant proteins in ruminant respiratory tract disease. Vet. Immunol. Immunop. 2005, 107, 91-96.
• 25. Okumura K., Itoh A., Isogai E., Hirose K., Hosokawa Y., Abiko Y., Shibata T., Hirata M., Isogai H.: C-terminal domain of human CAP18 antimicrobial peptide induces apoptosis in oral squamous cell carcinoma SAS-H1 cells. Cancer Lett. 2004, 212, 185-194.
• 26. Park C. H., Valore E. V., Waring A. J., Ganz T.: Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J. Biol. Chem. 2001, 276, 7806-7810.
• 27. Sang Y., Ramanathan B., Minton J. E., Ross C. R., Blecha F.: Porcine liverexpressed anitimicrobial peptides, hepcidin and LEAP-2: cloning and induction by bacterial infection. Dev. Comp. Immunol. 2006, 30, 357-366.
• 28. Scocchi M., Bontempo D., Boscolo S., Tomasinsig L., Giulotto E., Zanetti M.: Novel cathelicidins in horse leukocytes. FEBS Letters 1999, 457, 459-464.
• 29. Scocchi M., Shenglun W., Zanetti M.: Structural organization of bovine cathelicidin gene family and identification of a novel member. FEBS Letters 1997, 417, 311-315.
• 30. Selsted M. E., Novotny M. J., Morris W. L., Tang Y. Q., Smith W., Cullor J. S.: Indolicin, a novel bactericidal tridecapeptide amide from neutrophils. J. Biol. Chem. 1992, 267, 4292-4295.
• 31. Shamova O., Brogden K. A., Zhao C., Nguyen T., Kokryakov V. N., Lehrer R. I.: Purification and properties of proline-rich antimicrobial peptides from sheep and goat leukocytes. Infect. Immun. 1999, 67, 4106-4111.
• 32. Skerlavaj B., Benincasa M., Risso A., Zanetti M., Gennaro R.: SMAP-29: a potent antibacterial and antifungal peptide from sheep leucocytes. FEBS Letters 1999, 463, 58-62.
• 33. Skerlavaj B., Scocchi M., Gennaro R., Risso A., Zanetti M.: Structural and Functional Analysis of Horse Cathelicidin Peptides. Antimicrob. Agents 2001, 3, 715-722.
• 34. Suresh A., Verma Ch.: Modelling study of dimerization in mammalian defensins. Proc. Fifth Internat. Conf.: Bioinformatics - BMC. Bioinformatics 2006, 7, Supplement 5, s. 17.
• 35. Ślemp-Migiel A., Wiczkowski A.: Ludzkie endogenne białka i peptydy antybakteryjne. Praca przeglądowa. Ann. Acad. Med. Silesien. 2006, 60, 366-369.
• 36. Turner J., Cho Y., Dinh N. N., Waring A. J., Lehrer R. I.: Activities of LL-37, a cathelin-assiciated antimicrobial peptide of human neutrophils. Antimicrob. Agents 1998, 42, 2206-2214.
• 37. Wiechuła B. E., Tustanowski J. P., Martirosian G.: Peptydy antydrobnoustrojowe. Wiad. Lek. 2006, 59, 542-547.
• 38. Zanetti M.: Cathelicidins, multifunctional peptides of the innate immunity. J. Leukocyte Biol. 2004, 75, 39-48.
• 39. Zanetti M., Gennaro R., Romeo D.: Cathelicidins: a novel protein family with a common proregion ans a variable C-teminal antimicrobial domain. FEBS Letters 1995, 374, 1-5.
• 40. Zhang G., Ross C. R., Blecha F.: Porcine antimicrobial peptides: new prospects for ancient molecules of host defence. Vet. Res. 2000, 31, 277-296.
• 41. Zhao C., Ganz T., Lehrer R. I.: Structures of genes for two cathelin-associated antimicrobial peptides: prophenin-2 and PR-39. FEBS Letters 1995, 376, 130-134.